BUSINESS● LOWSep 11 · Sep 11, 2026, 3:10 PM
Drug Trial Setbacks Raise Questions Over Novartis (NVS)’s Growth Pipeline
Yahoo Finance · global
Novartis is facing questions regarding its growth pipeline due to recent setbacks in drug trials. These developments could impact the company's future financial performance and strategic direction.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS36m agoMinister inaugurates modern paddy storage facilities in Cuddalore districtThe HinduBUSINESS1h agoThe country as a laboratory, and the ghostsClarín